Expression Vector Element Combinations for Antibody Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current expression vector designs differ in performance between transient and stable transfections, requiring optimized vector organizations for each, and existing methods are inefficient in identifying high-producing cell clones for recombinant antibody production.
Innovation Solution
The use of expression vectors with specific promoter and polyA signal combinations, such as the human cytomegalovirus (hCMV) promoter with bovine growth hormone (bGH) polyA signal and human gastrin terminator, and the human elongation factor 1 alpha (hEF1α) promoter with bGH polyA signal, in unidirectional or bidirectional arrangements, to enhance antibody production and stability in mammalian cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional expression vector designs are used, then the basic function of protein expression is achieved, but the number of antibody-producing cells is limited and identification of high-producing clones is time-consuming
Solution Approach 1:
The patent optimizes vector elements (promoter strength, polyA signal sequence, transcription terminator) to change expression parameters, resulting in a 10-100 fold increase in antibody-producing cells and reduced time to identify high-producing clones
Solution Approach 2:
The patent incorporates pre-optimized expression elements and selection markers into the vector design before transfection, enabling rapid identification of high-producing clones without requiring extensive screening time
2Productivity
If expression vectors are optimized for transient transfection, then high expression levels are achieved in the short term, but stability of expression is reduced
Solution Approach 1:
The patent separates vector elements into distinct functional modules (promoter, polyA signal, terminator) that can be independently optimized for different transfection types, allowing tailored vector designs for transient versus stable expression
Solution Approach 2:
The patent modifies specific vector parameters (e.g., promoter strength, polyA signal sequence) to achieve different expression profiles - stronger promoters and optimized polyA signals for transient expression, while stable integration elements for long-term stable transfection
3Stability of the object's composition
If expression vectors are optimized for stable transfection, then long-term expression stability is achieved, but the number of antibody-producing cells is reduced
Solution Approach 1:
The patent divides vector elements into separate functional components that can be independently optimized, allowing the selection of optimal combinations for stable transfection that maximize both stability and productivity
Solution Approach 2:
The patent creates composite vector designs combining multiple optimized elements (e.g., hCMV promoter with bGH polyA signal and hGT terminator) to achieve synergistic effects that simultaneously improve stability and increase the number of antibody-producing cells
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Herein is reported that for transient transfections the use of the human elongation factor 1 alpha promoter (with Intron A) provides for an enhanced productivity (in LC-HC-SM organization), the use of the bovine growth hormone polyA signal sequence provides for an enhanced productivity compared to use of the SV40 polyA signal sequence, the addition of the HGT to the bGH PolyA signal sequence results in an increased productivity in vectors containing the hCMV promoter and the vector organization LC(3` -5 ')-HC-SM results in improved expression. For stable pools it is reported that pools generated with vectors containing the hEF1alpha promoter show an enhanced productivity in batch analysis, clones generated with vectors containing the hEF1alpha promoter show a reduced number of low producing clones, and clones generated with vectors containing the hEF1alpha promoter show a higher stability of IgG expression. For single clones it is reported that the vector organization with downstream position of selection marker (LC-HC-SM) has a positive effect on productivity of single clones and that clones generated with vectors containing the bGH polyA signal sequence and the hGT have higher productivities.